A detailed history of First American Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, First American Bank holds 120,319 shares of ABBV stock, worth $23.3 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
120,319
Previous 88,248 36.34%
Holding current value
$23.3 Million
Previous $11.9 Million 172610.01%
% of portfolio
1.54%
Previous 0.63%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $4.96 Million - $5.8 Million
32,071 Added 36.34%
120,319 $20.6 Billion
Q1 2024

Jul 31, 2024

BUY
$159.82 - $182.1 $1.05 Million - $1.2 Million
6,569 Added 5.74%
120,958 $22 Million
Q4 2023

Jul 31, 2024

BUY
$137.6 - $154.97 $130,720 - $147,221
950 Added 0.84%
114,389 $17.7 Million
Q3 2023

Jul 31, 2024

BUY
$133.59 - $154.65 $11,755 - $13,609
88 Added 0.08%
113,439 $16.9 Million
Q2 2023

Jul 31, 2024

SELL
$132.51 - $164.9 $1.21 Million - $1.51 Million
-9,135 Reduced 7.46%
113,351 $15.3 Million
Q1 2023

Jul 31, 2024

SELL
$144.61 - $166.54 $139,548 - $160,711
-965 Reduced 0.78%
122,486 $19.5 Million
Q4 2022

Jul 31, 2024

BUY
$138.31 - $165.87 $2.13 Million - $2.56 Million
15,421 Added 14.27%
123,451 $20 Million
Q3 2022

Jul 31, 2024

BUY
$134.21 - $153.93 $2.62 Million - $3.01 Million
19,555 Added 22.1%
108,030 $14.5 Million
Q2 2022

Jul 31, 2024

SELL
$137.62 - $174.96 $299,598 - $380,887
-2,177 Reduced 2.4%
88,475 $13.6 Million
Q1 2022

Jul 31, 2024

SELL
$131.98 - $163.75 $3.92 Million - $4.86 Million
-29,667 Reduced 24.66%
90,652 $14.7 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $34,162 - $43,225
318 Added 0.36%
88,248 $11.9 Million
Q3 2021

Oct 28, 2021

SELL
$106.4 - $120.78 $26,280 - $29,832
-247 Reduced 0.28%
87,930 $9.49 Million
Q2 2021

Jul 13, 2021

SELL
$105.21 - $117.21 $53,657 - $59,777
-510 Reduced 0.58%
88,177 $9.93 Million
Q1 2021

Apr 08, 2021

BUY
$102.3 - $112.62 $35,805 - $39,417
350 Added 0.4%
88,687 $9.6 Million
Q4 2020

Jan 06, 2021

SELL
$80.49 - $108.67 $124,035 - $167,460
-1,541 Reduced 1.71%
88,337 $9.47 Million
Q3 2020

Oct 09, 2020

SELL
$85.91 - $100.83 $76,889 - $90,242
-895 Reduced 0.99%
89,878 $7.87 Million
Q2 2020

Jul 13, 2020

BUY
$73.37 - $98.18 $7,410 - $9,916
101 Added 0.11%
90,773 $8.91 Million
Q1 2020

Apr 07, 2020

BUY
$64.5 - $97.79 $54,567 - $82,730
846 Added 0.94%
90,672 $6.91 Million
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $6.48 Million - $8.11 Million
89,826 New
89,826 $7.95 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First American Bank Portfolio

Follow First American Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First American Bank, based on Form 13F filings with the SEC.

News

Stay updated on First American Bank with notifications on news.